This was corroborated by another study that identified nine patients with non-MS inflammatory demyelinating diseases compatible with MOGAD and isolated CSF MOG-IgG positivity, eight of whom were found to have intrathecal MOG-IgG synthesis (71). This evidence concerns the gene MOG and myeloid sarcoma.